BioCardia, Inc. (BCDA) vs Jin Medical International Ltd. (ZJYL)
A side-by-side comparison of BioCardia, Inc. and Jin Medical International Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCDA
BioCardia, Inc.
$1.06HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ZJYL
Jin Medical International Ltd.
$1.99HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BCDA vs ZJYL
growth of $100 · dividends reinvested · last 4yBCDA -98.8% (-67.0%/yr)ZJYL -75.1% (-29.4%/yr)ZJYL compounded faster over this window
Log scale — wide-divergence pair
BCDA ZJYL
BCDA vs ZJYL: by the numbers
- •BCDA is the larger company ($16M vs $16M market cap).
- •ZJYL is profitable (5.76% net margin) while BCDA runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | BCDA | ZJYL |
|---|---|---|
| P/B ratio | 5.84 | 0.51 |
Profitability
| Metric | BCDA | ZJYL |
|---|---|---|
| Gross margin | 0.00% | 29.22% |
| Operating margin | 0.00% | 2.94% |
| Net margin | 0.00% | 5.76% |
| ROE | -271.81% | 4.02% |
| ROIC | -273.70% | 1.09% |
Growth (annualized)
| Metric | BCDA | ZJYL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.02% |
| EPS CAGR (5Y) | N/A | 6.40% |
| Total return CAGR (5Y) | -61.39% | N/A |
Frequently asked
- Is BCDA or ZJYL more profitable?
- ZJYL runs the higher net margin — BCDA at 0.00% versus ZJYL at 5.76%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.